Avalyn Pharma is a series c plus startup. 1 investor tracked.
Avalyn Pharma is a startup founded in 2017 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 5 investors associated with the company.
Avalyn Pharma focuses on the development of improved therapies for life-threatening pulmonary diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.